Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Effects of nucleotides and nucleosides on coagulation

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Prediction of bleeding by thromboelastography in ICU patients with haematological malignancy and severe sepsis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Valproic acid modulates platelet and coagulation function ex vivo

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Does whole blood coagulation analysis reflect developmental haemostasis?

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Changes in thrombin generation in children after cardiac surgery and ex-vivo response to blood products and haemostatic agents

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Coagulation competence and fluid recruitment after moderate blood loss in young men

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Nucleotides, including ADP, ATP and uridine triphosphate (UTP), are discharged profusely in the circulation during many pathological conditions including sepsis. Sepsis can cause hypotension and systemic activation of the coagulation and fibrinolytic systems in humans, which may cause disseminated intravascular coagulation. We investigated whether nucleotide-induced cardiovascular collapse as provoked by systemic infusion of adenosine, ADP, ATP, UTP and nitric oxide affected the haemostatic system as assessed by whole blood thromboelastography (TEG) analysis. Ten pigs received a randomized infusion of adenosine, ADP, ATP, UTP or nitric oxide until mean arterial pressure was reduced to approximately 40% of baseline simulating sepsis-induced hypotension. The effect of the infusions on the haemostatic system was evaluated by TEG, and endothelial release of tissue plasminogen activator and plasminogen activator inhibitor-1 was measured. In contrast to the other infused substrates, ADP caused a reduction in maximum amplitude (71.4 to 64.2; P <0.05), and reduced the angle, representing the thrombus formation (75.6 to 66.4; P <0.05), indicating hypocoagulation. Despite increases in t-PA release (2.1 to 2.7 ng/ml; P <0.05) and reductions in plasminogen activator inhibitor (33.9 +/- 10.9-17.8 +/- 4.4 ng/ml; P <0.05) no increased fibrinolysis was found when whole blood was evaluated by TEG. Circulating ADP induces hypocoagulation without signs of increased fibrinolysis as evaluated by TEG. The potential clinical significance of these findings should be investigated further because ADP discharged systemically may possibly contribute to the coagulopathy observed in severe sepsis.
Original languageEnglish
JournalBlood Coagulation and Fibrinolysis
Volume21
Issue number5
Pages (from-to)436-41
Number of pages6
ISSN0957-5235
DOIs
Publication statusPublished - 1 Jul 2010

ID: 31029616